Appeal to the FDA: no more silence on puberty-blocking drugs A petition asks the US drug agency -which has never authorised the off-label use of these substances for girls and boys with dysphoria- to counter the misinformation that propagates these treatments as effective and safe and to demand studies to prove it.Between 207 and 2021, the number of minors treated has more than doubled and the FDA can no longer pretend it is blind.
On his site Gender Clinic News Bernard Lane reports on an important petition to the FDA (Food and Drug Administration, US drug regulator) to take urgent action on the unapproved (off label) use of hormone suppressant drugs to block puberty in girls and boys who identify as transgender. Although this use has never been approved by the FDA, it is not possible for the agency to ignore the possible harm to minors who are subjected to these [...].
